Pittenger & Anderson Inc Actinium Pharmaceuticals, Inc. Transaction History
Pittenger & Anderson Inc
- $2.41 Billion
- Q1 2025
A detailed history of Pittenger & Anderson Inc transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Pittenger & Anderson Inc holds 341 shares of ATNM stock, worth $508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
341Holding current value
$508% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
69Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$2.41 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$1.02 Million0.0% of portfolio
-
State Street Corp Boston, MA621KShares$925,4010.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$743,8970.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $37.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...